Effects of Vitamin B12 and Folic Acid Supplementation on Negative Symptoms as the Primary Outcome and Positive and Cognitive Symptoms as Secondary Outcomes in Schizophrenia: A Randomized Controlled Trial
Iranian Journal of Psychiatry · 23.06.2026
DOI: 10.18502/ijps.v21i3.21863 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Iranian Journal of Psychiatry, online erschienen am 23.06.2026. Verfasst von Mahnaz Shah Ali und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
Persistent negative symptoms in chronic schizophrenia often show limited responsiveness to antipsychotic therapy. The present study evaluated whether supplementation with vitamin B12 and folic acid improves negative symptoms as the primary endpoint, while also examining effects on positive symptoms and global cognitive functioning as secondary outcomes.
Method
In this randomized, double-blind, placebo-controlled trial, 88 inpatients with chronic schizophrenia receiving stable risperidone therapy were assigned to one of four groups: vitamin B12 (1 mg/day), folic acid (1 mg/day), combined vitamin B12 plus folic acid (1 mg/day each), and placebo for eight weeks. Negative symptoms were measured using the Scale for the Assessment of Negative Symptoms (SANS), positive symptoms using the Scale for the Assessment of Positive Symptoms (SAPS), and cognitive function using the Mini-Mental State Examination (MMSE). Serum concentrations of vitamin B12 and folate were assessed at baseline and after the intervention.
Results
Supplementation with vitamin B12 and/or folic acid led to significant increases in serum concentrations of the corresponding vitamins (P < 0.001). All supplementation groups demonstrated significant and clinically meaningful reductions in negative symptom severity compared with placebo, with large effect sizes. In contrast, no significant changes were detected in positive symptoms or global cognitive performance.
Conclusion
Adjunctive vitamin B12 and folic acid supplementation significantly reduced negative symptom severity in chronic schizophrenia, without affecting positive symptoms or global cognition. Targeted correction of vitamin deficiencies may represent a valuable adjunctive approach for persistent negative symptoms.
Zitieren
APA
Ali, M. S., Rezaei, O., Shideh, R. M., & Sadighi, G. (2026). Effects of Vitamin B12 and Folic Acid Supplementation on Negative Symptoms as the Primary Outcome and Positive and Cognitive Symptoms as Secondary Outcomes in Schizophrenia: A Randomized Controlled Trial. Iranian Journal of Psychiatry. https://doi.org/10.18502/ijps.v21i3.21863
Vancouver
Ali MS, Rezaei O, Shideh RM, Sadighi G. Effects of Vitamin B12 and Folic Acid Supplementation on Negative Symptoms as the Primary Outcome and Positive and Cognitive Symptoms as Secondary Outcomes in Schizophrenia: A Randomized Controlled Trial. Iranian Journal of Psychiatry. 2026. doi:10.18502/ijps.v21i3.21863
BibTeX
@article{Ali2026,
author = {Ali, Mahnaz Shah and Rezaei, Omid and Shideh, Reza Momeni and Sadighi, Gita},
title = {Effects of Vitamin B12 and Folic Acid Supplementation on Negative Symptoms as the Primary Outcome and Positive and Cognitive Symptoms as Secondary Outcomes in Schizophrenia: A Randomized Controlled Trial},
journal = {Iranian Journal of Psychiatry},
year = {2026},
doi = {10.18502/ijps.v21i3.21863}
}
EUVIMED